Disposition of Inventories of Products. Following termination of this Agreement with respect to one or more Research Project Targets, Pfizer, its Affiliates and its Sublicensees shall have the right to continue to sell their existing inventories of Licensed Product(s) Targeting such Research Project Targets that have received Regulatory Marketing Approval prior to such termination for a period not to exceed [***] after the effective date of such termination or expiration and Pfizer shall pay any royalties payable in connection with such sales in accordance with Section 5.5.
Appears in 3 contracts
Samples: Research Collaboration, Option and License Agreement (CytomX Therapeutics, Inc.), Research Collaboration, Option and License Agreement (CytomX Therapeutics, Inc.), Research Collaboration, Option and License Agreement (CytomX Therapeutics, Inc.)
Disposition of Inventories of Products. Following termination of this Agreement with respect to one or more Research Project Pfizer Targets, Pfizer, its Affiliates and its Sublicensees shall will have the right to continue to sell their existing inventories of Pfizer Licensed Product(s) Targeting such Research Project Pfizer Targets that have received Regulatory Marketing Approval prior to such termination for a period not to exceed [***] after the effective date of such termination or expiration and Pfizer shall will pay any royalties payable in connection with such sales in accordance with Section 5.5.
Appears in 2 contracts
Samples: Research Collaboration and License Agreement (Allogene Therapeutics, Inc.), Research Collaboration and License Agreement (Cellectis S.A.)
Disposition of Inventories of Products. Following termination of this Agreement with respect to one or more Research Project Targets, Pfizer, its Affiliates and its Sublicensees shall have the right to continue to sell their existing inventories of Licensed Product(s) Targeting such Research Project Targets that have received Regulatory Marketing Approval prior to such termination for a period not to exceed [***] six (6) months after the effective date of such termination or expiration and Pfizer shall pay any royalties payable in connection with such sales in accordance with Section 5.5.
Appears in 2 contracts
Samples: Research Collaboration, Option and License Agreement (CytomX Therapeutics, Inc.), Research Collaboration, Option and License Agreement (CytomX Therapeutics, Inc.)